Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

COCP US Equity

Cocrystal Pharma, Inc.Health Care · Pharmaceutical Preparations · CIK 1412486 · FY ends Dec 31
$1.15
+0.06 (+6.02%)
USD · as of 2026-08-19 · marketstack
4 8-K filings · 2 13D · 0 13G
DateEventWhat happened / filerSource
2026-08-188-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-178-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-0713DSchedule 13D filed — ≥5% beneficial owner (active intent) · by OPKO HEALTH, INC.sec.gov ↗
2026-08-0713D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by FROST PHILLIP MD ET ALsec.gov ↗
2026-08-038-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-038-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-038-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-178-K 5.07Submission of matters to a vote of security holderssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-17

Every row is a filed document, checked against its EDGAR index.